Benzinga's M&A Chatter for Wednesday August 13, 2014
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday August 13, 2014:
Report Sanofi, Roche Bid for Intermune
Shares of Intermune (NASDAQ: ITMN) spiked sharply higher Wednesday, on a report from Bloomberg that Sanofi (NYSE: SNY) and Roche (OCT: RHHBY) had submitted bids for the Brisbane, CA-based biotech company, according to sources. Centerview Partners and Goldman Sachs Group are reportedly advisors on the strategic review, which is said to be in the early stages. Intermune is said not to be soliciting takeover offers.
Intermune shares closed Wednesday at $52.06, a gain of more than 14%.
Constellation Brands to Acquire Casa Noble Tequila, No Terms Disclosed
Constellation Brands (NYSE: STZ) (NYSE: STZ.B) announced Wednesday it will acquire the Casa Noble tequila brand, including the Casa Noble trademark and related assets. The deal is expected to close in September 2014. Terms of the purchase were not disclosed.
Constellation Brands closed at $85.88 Wednesday, a gain of $0.15.
MedAssets to Acquire SG-2 For $142M
MedAssets (NASDAQ: MDAS) announced Wednesday, it has agreed to acquire privately held SG-2, LLC (Sg2) for approximately $142 million, to be funded with cash on hand and borrowings under its existing credit facility.
The deal is expected to close in 60 to 90 days.
MedAssets closed Wednesday at $21.93, a gain of 1.5%.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.